Why Participate in Clinical Research?
You will contribute to the wellbeing of society, and the advancement of medical research, bringing new hope for patients afflicted with different conditions and diseases. Future generations, your children or grandchildren included, will benefit from the research. It may also benefit you, as you can learn more about your illness or condition and the treatment options, and have access to new medications and procedures. Whatever your reasons, participation is voluntary. We invite you to join us in gaining better understanding of diseases and improving healthcare in Singapore.
Monogenic Hypertension Research
Information
Eligibility:
- High blood pressure before 30 years old
- High blood pressure between 30 - 40 years old and family history of hypertension
- Uncontrolled high blood pressure despite taking 3 or more blood pressure lowering medications
- Your doctor suspects that you may have Monogenic Hypertension
Contact Number:
8938 2077 / 9646 6874
Email:
[email protected]
Time:
Monday - Friday,
9am - 12pm or 1pm - 5pm
Collection, use and disclosure of your personal data shall be in accordance with our
privacy policy
Diabetes Study
We are looking for volunteers for a 3-year study to find out which of two treatment processes is better at treating Type 2 Diabetes in overweight patients: Surgery or the best medical treatment.
Information
Eligibility:
- Type 2 diabetes for less than 10 years
- Age 21 – 65 years old
- BMI between 27 - 32
- Willing to have either surgery or the best medical treatment
- Not pregnant or planning to get pregnant before the end of the study
Contact :
973 874 08
Email:
[email protected]
Collection, use and disclosure of your personal data shall be in accordance with our
privacy policy
SMART2D Study
We are calling for research volunteers who have taken part in the diabetes study in 2011-2014 organised by Khoo Teck Puat Hospital's Clinical Research Unit to participate in a follow-up study. This research investigates the risk factors affecting blood vessel function, eye, kidney and foot complications in people with Type 2 diabetes.
Information
Eligibility:
- Aged 21 to 90 years old
- Have Type 2 Diabetes
- Not pregnant
Contact :
8128 9442 (Amy)
8798 3468 (Xiaoge)
8798 3592 (Siti)
9113 5891 (Wei Rou)
Email:
[email protected]
Time:
Monday - Friday,
9am - 12pm or 2pm - 4.30pm
Familial Clustering of Diabetes Kidney Disease
DKD is a common diabetic complication which affects the kidneys. Over time, kidney function is lost, leading to the need for dialysis. DKD patients commonly experience a loss in their quality of life.
Research has shown that DKD tends to occur more frequently within families with a history of DKD. This pattern may be caused by a shared lifestyle among family members. This includes shared diet and behavior.
Information
Eligibility:
- T2DM
≥ 10 years
- At least 2 family members can join
- Family members need not to be T2DM
≥10 years
Contact Number:
Office - 6602 3311
HP - 9758 6282 (8am - 8pm)
Email:
[email protected]
Collection, use and disclosure of your personal data shall be in accordance with our
privacy policy
Monogenic Diabetes Study
MODY (Maturity-Onset Diabetes of the Young) is a form of monogenic diabetes that is caused by a single gene abnormality (mutation). Our research study aims to identify potential MODY patients for genetic testing in order to determine the mutation which will help doctors better understand the disease and treat the patients. The MODY Registry provides a platform to gather information for further studies of monogenic diabetes that will serve the interests of patients and healthcare providers.
Information
Principal Investigator:
A/Prof Lim Su Chi
Senior Consultant, Diabetes Centre
Clinical Director,
Clinical Research Unit, Khoo Teck Puat Hospital
Recruitment Period:
Until 30 September 2021
Eligibility:
- Age 0-99 years
- Diabetes diagnosed at 35 years old or less
- Additional criteria applies (eligibility to be confirmed by study team)
Cost:
For eligible and consented participants:
- No charge for tests performed as part of the study
- One-time transport reimbursement provided
Contact :
9755 2352 (Li Xian)
9839 9844 (Lovynn)
Email:
[email protected]
Time:
Monday - Friday,
9am - 12pm or 2pm - 4.30pm
Collection, use and disclosure of your personal data shall be in accordance with our
privacy policy
FHCARE Research Study
Information
Recruitment Period:
Until 31 March 2030
Eligibility (must fulfill all the criteria):
- Total Cholesterol > 7.5 mmol/L and/or LDL cholesterol > 4.9 mmol/L
- Family history of high cholesterol and heart diseases
What the study involves:
- Up to 2 visits
- Family history taking
- Sample collection for genetic testing
Cost:
Cost of genetic test for Familial Hypercholesterolemia (FH) will be
advised by the team upon request.
Contact :
6807 8212 / 6602 2346
9863 7690 (Atiqa)
9674 5167 (Husna)
9825 9793 (Sharmaine)
9119 4957 (Madhuu)
Email:
[email protected]
Website:
Familial Hypercholesterolemia
Time:
Monday - Friday,
9am - 12pm or 2pm - 5pm
Collection, use and disclosure of your personal data shall be in accordance with our
privacy policy
You may contact the study teams for specific studies as listed in the recruitment posters above.
Alternatively, you may
click here to register your interest to be part of our research volunteers database. We will contact you when there is a suitable study.
Participant Information & Rights
Association for the Accreditation of Human Research Protection Programs
For our efforts in achieving a high standard for ethics, quality and protection of people in research, KTPH is one of the few institutions in Singapore to be awarded the Full Accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
AAHRPP is a non-profit organisation that accredits institutions conducting research for achieving high quality of research work and protection of participants.
To attain the accreditation, KTPH has to submit report on its Human Research Protection Programs and undergo stringent on-site review by a team of experts from AAHRPP at scheduled intervals. For more information, please visit
AAHRPP website.
ICH E6(R2) Good Clinical Practice (ICH E6 GCP) Guidelines
At KTPH, the wellbeing and safety of research participants take precedence above all our activities. To ensure the protection of our participants in clinical trial and reliability of clinical trial results, KTPH adheres to the guideline provided by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). For more information and copy of the guidelines, please visit the
ICH website.
All clinical research or clinical trials require ethics approval prior to commencement.